Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » SpeeDx, LabCorp Will Codevelop MDx Tests

SpeeDx, LabCorp Will Codevelop MDx Tests

Jan 13, 2020
|
staff reporter

NEW YORK – SpeeDx said on Monday it has agreed with Laboratory Corporation of America to codevelop diagnostic tests . The agreement focuses on assays for women's health and infectious diseases.

SpeeDx and LabCorp will work together to codevelop and introduce new molecular tests using SpeeDx's proprietary technology, the Australia-based firm said in an email. Financial terms were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Suit and Settlement

Los Angeles brought and settled a civil enforcement action against the makers of an at-home test for SARS-CoV-2, NPR reports. 

CRUK Announces Cuts

The Guardian reports that Cancer Research UK is cutting its research funding by £44 million.

Long Wait

Technology Review examines factors affecting SARS-CoV-2 testing turnaround times.

PNAS Papers on Ancient European Migrations, Triple-Negative Breast Cancer Fusions, More

In PNAS this week: mapping of ancient human migrations in Europe, recurrent gene fusion in breast cancer, and more.

What's Popular?

In Business News

  1. FDA Issues Emergency Use Authorization for Viracor Eurofins Coronavirus LDT

  2. Coronavirus Pandemic Expected to Significantly Disrupt Hologic Q2 Revenues

  3. Thermo Fisher Preliminary Q1 Revenues up 1 to 2 Percent; Firm Withdraws 2020 Guidance

  4. FDA Issues Emergency Use Authorization for Gnomegen Coronavirus Test

  5. NanoString Preliminary Q1 Revenues Take Hit From COVID-19, Firm Withdraws 2020 Guidance

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.